APA (7th ed.) Citation

LND, A., E, K., X, S., D, V., HD, K., I, M., . . . MC, C. (2024). Prevalence and impact of the KIT M541L variant in patients with mastocytosis. Oncotarget, 15, 521. https://doi.org/10.18632/oncotarget.28614

Chicago Style (17th ed.) Citation

LND, Aldama, Karlins E, Sun X, Veltri D, Komarow HD, Maric I, Metcalfe DD, and Carter MC. "Prevalence and Impact of the KIT M541L Variant in Patients with Mastocytosis." Oncotarget 15 (2024): 521. https://doi.org/10.18632/oncotarget.28614.

MLA (9th ed.) Citation

LND, Aldama, et al. "Prevalence and Impact of the KIT M541L Variant in Patients with Mastocytosis." Oncotarget, vol. 15, 2024, p. 521, https://doi.org/10.18632/oncotarget.28614.